Emerald Advisers, LLC Travere Therapeutics, Inc. Transaction History
Emerald Advisers, LLC
- $2.53 Billion
- Q2 2025
A detailed history of Emerald Advisers, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Emerald Advisers, LLC holds 2,091,360 shares of TVTX stock, worth $36.4 Million. This represents 1.22% of its overall portfolio holdings.
Number of Shares
2,091,360
Previous 2,077,173
0.68%
Holding current value
$36.4 Million
Previous $37.2 Million
16.84%
% of portfolio
1.22%
Previous 1.85%
Shares
9 transactions
Others Institutions Holding TVTX
# of Institutions
230Shares Held
102MCall Options Held
1.71MPut Options Held
401K-
Janus Henderson Group PLC London, X09.54MShares$166 Million0.07% of portfolio
-
Armistice Capital, LLC New York, NY8.88MShares$155 Million2.3% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$133 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.99MShares$104 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C35.1MShares$88.7 Million0.1% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.12B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...